CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON'S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA'S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
J Parkinsons Dis
.
2019;9(2):251-264.
doi: 10.3233/JPD-199001.
Authors
Kevin McFarthing
1
,
Neha Prakash
2
,
Tanya Simuni
2
Affiliations
1
Parkinson's Advocate, Innovation Fixer Ltd, Oxford, UK.
[email protected]
.
2
Parkinson's Disease and Movement Disorders Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
PMID:
31127735
PMCID:
PMC6598021
DOI:
10.3233/JPD-199001
No abstract available
Associated data
ClinicalTrials.gov/NCT03562494
ClinicalTrials.gov/NCT03720418
ClinicalTrials.gov/NCT01621581
ClinicalTrials.gov/NCT02605434